Venezuela approves Russian Sputnik Light Single-Dose Coronavirus Vaccine

The Ministry of Health of Venezuela has approved the Russian single-dose vaccine against coronavirus, Sputnik Light, reported this Saturday the Russian Direct Investment Fund (FIDR) in a statement.

Sputnik Light, developed with the first component of the Russian two-dose Sputnik V vaccine, has an efficacy of 79.4% 28 days after inoculation, according to the fund.

The FIDR supports its data on information collected between December 5 and April 15 from Russians who for some reason only received the first dose of Sputnik V.

The results of the Sputnik Light clinical trials have yet to be published in independent medical journals.

Russia claims that an efficiency level close to 80% “is much higher than many two-dose vaccines”.

Venezuela Sputnik V was already approved last January, which has been authorized so far in 65 countries with a total population of more than 3.2 billion citizens.

Both the Sputnik V as the light version (light) can be stored at a temperature between 2 and 8 degrees Celsius and its price is below 10 dollars a dose and protects against known strains of covid-19.

Russia registered the Sputnik Light on May 6.

According to the director of the Gamaleya Center, which develops both Russian vaccines, Alexandr Ginzburg, the Sputnik Light can be a good option for both initial vaccination and revaccination.